NASDAQ:TGTX
TG Therapeutics Stock News
$16.60
+0.120 (+0.728%)
At Close: May 21, 2024
NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of final results from the Phase 3 GENUINE trial evaluating ublituximab, the Company's i
Is This Cheap Cancer-Drug Company a Top Stock to Buy Now?
06:25am, Friday, 19'th Feb 2021
Large biotechs are taking over small-cap companies (and their cancer treatments) left and right. Could this business be the next target?
TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib)
01:55pm, Friday, 05'th Feb 2021
UKONIQ is approved for adult patients with relapsed or refractory marginal zone lymphoma after at least one prior anti-CD20 based regimen
TG Therapeutics to Participate in the B. Riley Securities Oncology Investor Conference
07:00am, Friday, 15'th Jan 2021
Fireside chat scheduled for Wednesday, January 20, 2021 at 10:00 AM ET Fireside chat scheduled for Wednesday, January 20, 2021 at 10:00 AM ET
TG Therapeutics CEO on developing treatments for patients with multiple sclerosis
07:21pm, Wednesday, 13'th Jan 2021
TG Therapeutics CEO Mike Weiss explained the biopharmaceutical company's plans to address the multiple sclerosis drug market and carve a lane away from competitors in the space.
TG Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
07:00am, Friday, 08'th Jan 2021
Presentation scheduled for Tuesday, January 12, 2021 at 2:00 PM ET Presentation scheduled for Tuesday, January 12, 2021 at 2:00 PM ET
TG Therapeutics Shares Climb on Study Results
02:56pm, Saturday, 02'nd Jan 2021
After a protracted wait, TG Therapeutics Inc. (NASDAQ:TGTX) shareholders finally got rewarded for their patience last month when the stock began a rapid climb to its current price of $52. That's a gai
3 Soaring MedTech Stocks That Might Lose Ground in 2021
09:47am, Wednesday, 30'th Dec 2020
Despite MedTech industry's bright prospects in 2021, investors should be wary of stocks like BLFS, STAA and TGTX, given their unfavorable Zacks Rank and weak fundamentals.
Are Options Traders Betting on a Big Move in TG Therapeutics (TGTX) Stock?
09:47am, Thursday, 24'th Dec 2020
Investors need to pay close attention to TG Therapeutics (TGTX) stock based on the movements in the options market lately.
3 FDA Dates Biotech Investors Should Circle in 2021
07:34am, Thursday, 24'th Dec 2020
These biotech stocks could sink or soar following some important approval decisions slated for the new year.
TG Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
07:52pm, Monday, 14'th Dec 2020
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company developing medicines for patients with B-cell mediated diseases (“the Company”), today
TG Therapeutics Announces Proposed Public Offering of Common Stock
07:31am, Monday, 14'th Dec 2020
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases (“TG Therap
TG Therapeutics Stock Jumps On Positive Results For Multiple Sclerosis Treatment
11:15am, Thursday, 10'th Dec 2020
TG Therapeutics stock jumped after the biotech firm announced positive top-line results from two phase 3 studies for its Ublituximab treatment of multiple sclerosis patients. The post TG Therapeutics
Both studies met their primary endpoint of significantly reducing annualized relapse rate ( ARR ) (p
UNITY-CLL: U2 significantly improved progression-free survival over obin utuz u mab plus chlorambucil (HR= 0 .54, p
